The researchers of the Polytechnic University of Madrid have developed a new biomarker that could be useful at the time of making a diagnosis early on Alzheimer’s, which could display the results by using a magnetic resonance imaging.
In order to prevent the death of millions of people by this degenerative disease, the group of researchers, led by the Centre for Biomedical Technology (CTB) of the university, I think what seems to be a definitive test to detect the disease before the patient dies.
The data that have been collected in its multiple probes, indicate that the iron deposits in the brain are one of the common characteristics in that they have all the people who have Alzheimer’s and that may be the source of it.
In this way they thought they would need to create contrast agents that allow for greater sensitivity in magnetic resonance imaging for the detection of incipient accumulations of iron-associated amyloid plaques in the brain of patients with Alzheimer’s disease.
With this basis, began to develop a contrast agent for magnetic resonance imaging, which is based on magnetic nanoparticles functionalized and that could function as a biomarker for the early diagnosis of the disease.
This is how you would quickly and efficiently the accumulation of iron in the brain and may begin a preventive treatment against the disease, saving some of the 47 million patients around the world cope with, without being invasive in the brain.
The results of the studies that have been conducted and that have been published in the journal ACS Chemical Neuroscience, show that this could be a great step towards a malaise that seems to have no end but death:
“This can open the way to new research to get methods of early diagnosis and non-invasive of this neurodegenerative disease, which today is not possible”.